Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial
在2型糖尿病患者中,洛贝格列酮联合二甲双胍和西格列汀治疗的疗效和安全性:一项为期52周、多中心、随机、安慰剂对照的III期临床试验
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16625
Hong, Eun-Gyoung; Min, Kyung-Wan; Chun, SungWan; Chung, Choon Hee; Oh, Seungjoon; Lee, Chang Beom; Kim, Dong-Jun; Kim, Hye Soon; Mok, Ji Oh; Sohn, Tae Seo; Park, Jeong Hyun; Choi, Sung Hee; Kim, Sungrae; Kim, Sang Soo; Hur, Kyu Yeon; Kim, Chong Hwa; Cho, Young Min; Kim, Byung-Joon; Yoon, Kun-Ho